Kenya - English - Pharmacy and Poisons Board

pro med pharmaceutical ltd off mombasa road, behind nice & lovely go downs, - diphenhydramine hcl, ammonium chloride. - syrup - diphenhydramine hcl 12mg, ammonium chloride125mg. - diphenhydramine

Namibia - English - Namibia Medicines Regulatory Council

alliance pharma (pty) ltd - diphenhydramine hcl , sodium citrate , ammonium chloride , menthol - syrup - each 10ml of syrup contains:diphenhydramine hcl 28.15mg, sodium citrate 113.83mg, ammonium chloride 273.86mg, menthol 2.28mg

Kenya - English - Pharmacy and Poisons Board

dawa limited p.o. box 16633-00620 nairobi, kenya - diphenhydramine hcl,ammonium chloride, sodium… - syrup - each 5ml contains diphenhydramine hcl bp… - expectorants excluding combinations with cough

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

wallace manufacturing chemists ltd - diphenhydramine hydrochloride; ammonium chloride; menthol - oral solution - 2.8mg/1ml ; 27mg/1ml ; 220microgram/1ml

Malta - English - Medicines Authority

wallace manufacturing chemists limited - ammonium chloride, diphenhydramine hydrochloride, menthol - syrup - ammonium chloride 135 milligram(s)/5 millilitre ; diphenhydramine hydrochloride 14 milligram(s)/5 millilitre ; menthol 1.1 milligram(s)/5 millilitre - cough and cold preparations

Malta - English - Medicines Authority

simru global holdings limited the black church, st. mary’s place, dublin 7, d07 p4ax , ireland - ammonium chloride, diphenhydramine hydrochloride, menthol - syrup - ammonium chloride 135 mg/5ml diphenhydramine hydrochloride 14 mg/5ml menthol 1.1 mg/5ml - cough and cold preparations

United States - English - NLM (National Library of Medicine)

fresenius kabi usa, llc - diphenhydramine hydrochloride (unii: tc2d6jad40) (diphenhydramine - unii:8gts82s83m) - diphenhydramine hydrochloride 50 mg in 1 ml - diphenhydramine hydrochloride in the injectable form is effective in adults and pediatric patients, other than premature infants and neonates, for the following conditions when diphenhydramine hydrochloride in the oral form is impractical. antihistaminic: for amelioration of allergic reactions to blood or plasma, in anaphylaxis as an adjunct to epinephrine and other standard measures after the acute symptoms have been controlled, and for other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated. motion sickness: for active treatment of motion sickness. antiparkinsonism: for use in parkinsonism, when oral therapy is impossible or contraindicated, as follows: parkinsonism in the elderly who are unable to tolerate more potent agents; mild cases of parkinsonism in other age groups, and in other cases of parkinsonism in combination with centrally acting anticholinergic agents. use in neonates or premature infants: this drug should not be used

United States - English - NLM (National Library of Medicine)

contract pharmacy services-pa - diphenhydramine hydrochloride (unii: tc2d6jad40) (diphenhydramine - unii:8gts82s83m) - diphenhydramine hydrochloride 50 mg - diphenhydramine hydrochloride in the oral form is effective for the following indications: for allergic conjunctivitis due to foods; mild, uncomplicated allergic skin manifestations of urticaria and angioedema; amelioration of allergic reactions to blood or plasma; dermatographism; as therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled. for active and prophylactic treatment of motion sickness. for parkinsonism (including drug-induced) in the elderly unable to tolerate more potent agents; mild cases of parkinsonism (including drug-induced) in other age groups; in other cases of parkinsonism (including drug-induced) in combination with centrally acting anticholinergic agents. nighttime sleep-aid. this drug should not be used in newborn or premature infants. because of the higher risk of antihistamines for infants generally, and for newborns and prematures in particular, antihistamine therapy is contraindicated in nursing

United States - English - NLM (National Library of Medicine)

state of florida doh central pharmacy - diphenhydramine hydrochloride (unii: tc2d6jad40) (diphenhydramine - unii:8gts82s83m) - diphenhydramine hydrochloride 50 mg - diphenhydramine hydrochloride in the oral form is effective for the following indications: for allergic conjunctivitis due to foods; mild, uncomplicated allergic skin manifestations of urticaria and angioedema; amelioration of allergic reactions to blood or plasma; dermatographism; as therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled. for active and prophylactic treatment of motion sickness. for parkinsonism (including drug-induced) in the elderly unable to tolerate more potent agents; mild cases of parkinsonism (including drug-induced) in other age groups; in other cases of parkinsonism (including drug-induced) in combination with centrally acting anticholinergic agents. nighttime sleep-aid. this drug should not be used in newborn or premature infants. because of the higher risk of antihistamines for infants generally, and for newborns and prematures in particular, antihistamine therapy is contraindicated in nursing

United States - English - NLM (National Library of Medicine)

mylan institutional llc - diphenhydramine hydrochloride (unii: tc2d6jad40) (diphenhydramine - unii:8gts82s83m) - diphenhydramine hydrochloride 50 mg in 1 ml - diphenhydramine hydrochloride injection, is effective in adults and pediatric patients, other than premature infants and neonates, for the following conditions when diphenhydramine hydrochloride in the oral form is impractical. for amelioration of allergic reactions to blood or plasma, in anaphylaxis as an adjunct to epinephrine and other standard measures after the acute symptoms have been controlled, and for other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated. for active treatment of motion sickness. for use in parkinsonism, when oral therapy is impossible or contraindicated, as follows: parkinsonism in the elderly who are unable to tolerate more potent agents; mild cases of parkinsonism in other age groups, and in other cases of parkinsonism in combinations with centrally acting anticholinergic agents. this drug should not be used in neonates or premature infants. because of the higher risk of antihistamines for infants generally, and for neonat